Main
Archive
4(1) (132) – VII/VIII 2019
Іssue: 4(1) (132) – VII/VIII 2019
Last issues:
6 (164) – XI/XII 2024
5 (163) – IX/X 2024
4 (162) – VII/VIII 2024
Last issue:
4(1) (132) – VII/VIII 2019
For a medical practitioner
Canephron
®
N — proven efficiency and reasonable alternative to antibiotics in treatment of uncomplicated urinary tract infections
Osadchy O.I.
Nephrology and Urology
|
Therapy, General practice
|
PDF
|
Differential diagnosis and treatment of heartburn in practice of a family doctor
Mosiychuk L.M.
|
Petishko O.P.
|
Vasiliev I.O.
Gastroenterology
|
Therapy, General practice
|
PDF
|
Psychosomatic masks of anxiety
Khaustоva O.O.
Neurology and Psychiatry
|
PDF
|
Research article
Bioequivalence of the medicinal product Preventor (rosuvastatin), film-coated tablets, to the reference medicinal product Crestor
®
(rosuvastatin), film-coated tablets, in a randomized crossover clinical trial in healthy volunteers
Doroshenko A.
|
Sotnychenko N.M.
|
Kubeš V.
|
Kuznetsov I.E.
|
Tsapko G.V.
Cardiology, Rheumatology
|
Therapy, General practice
|
PDF
|
Bioequivalence of amlodipine, hydrochlorothiazide and valsartan fixed-dose combination generic medicinal product (Tiara Trio
®
) to the reference medicinal product Exforge HCT
®
: results of a randomized crossover clinical trial in healthy volunteers
Artysh B.
|
Doroshenko A.
|
Sotnychenko N.M.
|
Kubeš V.
Cardiology, Rheumatology
|
Therapy, General practice
|
Pharmacology
|
PDF
|